Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Archit Organosys's ROE % for the quarter that ended in Mar. 2026 was 10.61%. Archit Organosys's PB Ratio for the quarter that ended in Mar. 2026 was 0.97.
Archit Organosys's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 10.94%.
Archit Organosys ROE % Adjusted to Book Value Related Terms
Archit Organosys ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Archit Organosys's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Archit Organosys ROE % Adjusted to Book Value Chart
BOM:524640 vs DOW: ROE % Adjusted to Book Value Comparison
For the Chemicals subindustry, Archit Organosys's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Archit Organosys ROE % Adjusted to Book Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Archit Organosys's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Archit Organosys's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 10.94% mean?
Archit Organosys (BOM:524640) has a ROE % Adjusted to Book Value of 10.94% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Archit Organosys and its competitors.
Is Archit Organosys' ROE % Adjusted to Book Value too high?
Archit Organosys' current ROE % Adjusted to Book Value is 10.94%. Overall, Archit Organosys has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Archit Organosys' ROE % Adjusted to Book Value compare to DOW?
Archit Organosys' ROE % Adjusted to Book Value of 10.94% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Chemicals company?
A good ROE % Adjusted to Book Value depends on the Chemicals industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Archit Organosys and its competitors. Archit Organosys's current ROE % Adjusted to Book Value is 10.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Archit Organosys stock overvalued right now?
Based on GuruFocus' analysis, Archit Organosys (BOM:524640) is currently considered Fairly Valued. The stock's GF Value™ is ₹55.23, compared to a current price of ₹55.57 — trading 0.6% above its estimated fair value. The current ROE % Adjusted to Book Value is 10.94%. Archit Organosys' overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Archit Organosys (BOM:524640), the current ROE % Adjusted to Book Value is 10.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Archit Organosys (BOM:524640) Overvalued in 2026?
Based on GuruFocus' analysis, Archit Organosys stock appears to be overvalued.
The current stock price of ₹55.57 is trading 0.6% above its estimated GF Value™ of ₹55.23.
GuruFocus considers Archit Organosys to be Fairly Valued.
Key valuation signals for BOM:524640:
ROE % Adjusted to Book Value: 10.94%
GF Value™: ₹55.23 vs. price of ₹55.57 (0.6% above fair value)
No single metric tells the full story. See the BOM:524640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Archit Organosys Ltd is mainly engaged in the manufacturing and selling of various chemical products, including alkali chemicals, inorganic chemicals, organic chemicals, pesticides and insecticides, dyes, and dyestuff. The company mainly manufactures and trades chemicals such as Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloroacetyl Chloride, and Trichloroacetyl Chloride (TCAC). It operates in a single segment identified as manufacturing and trading of dyes, chemicals, and pigments. Geographically, it derives the majority of its revenue from India and also exports products to other countries.
65GF Score
Get the complete analysis for BOM:524640
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524640 has been successfully added to your 
